CIENCIASMEDICASNEWS: Statement—NIH-Sponsored ACTIV-3 Clinical Trial Closes Enrollment into Two Sub-Studies | NIH: National Institute of Allergy and Infectious Diseases

viernes, 5 de marzo de 2021

Statement—NIH-Sponsored ACTIV-3 Clinical Trial Closes Enrollment into Two Sub-Studies | NIH: National Institute of Allergy and Infectious Diseases

Statement—NIH-Sponsored ACTIV-3 Clinical Trial Closes Enrollment into Two Sub-Studies | NIH: National Institute of Allergy and Infectious Diseases

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)